- Home
- YSXT vs ACHV Comparison
YSXT vs ACHV Comparison
Compare YSXT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- ACHV
- Stock Information
- Founded
- YSXT 2011
- ACHV N/A
- Country
- YSXT China
- ACHV Canada
- Employees
- YSXT N/A
- ACHV N/A
- Industry
- YSXT Automotive Aftermarket
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- YSXT Consumer Discretionary
- ACHV Health Care
- Exchange
- YSXT Nasdaq
- ACHV Nasdaq
- Market Cap
- YSXT 79.2M
- ACHV 72.5M
- IPO Year
- YSXT 2024
- ACHV N/A
- Fundamental
- Price
- YSXT $4.52
- ACHV $2.36
- Analyst Decision
- YSXT
- ACHV Strong Buy
- Analyst Count
- YSXT 0
- ACHV 3
- Target Price
- YSXT N/A
- ACHV $14.33
- AVG Volume (30 Days)
- YSXT 52.5K
- ACHV 220.8K
- Earning Date
- YSXT 02-24-2025
- ACHV 05-08-2025
- Dividend Yield
- YSXT N/A
- ACHV N/A
- EPS Growth
- YSXT N/A
- ACHV N/A
- EPS
- YSXT 0.18
- ACHV N/A
- Revenue
- YSXT $66,143,276.00
- ACHV N/A
- Revenue This Year
- YSXT N/A
- ACHV N/A
- Revenue Next Year
- YSXT N/A
- ACHV N/A
- P/E Ratio
- YSXT $27.40
- ACHV N/A
- Revenue Growth
- YSXT 21.23
- ACHV N/A
- 52 Week Low
- YSXT $2.06
- ACHV $1.84
- 52 Week High
- YSXT $6.27
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- ACHV 47.12
- Support Level
- YSXT N/A
- ACHV $1.95
- Resistance Level
- YSXT N/A
- ACHV $2.63
- Average True Range (ATR)
- YSXT 0.00
- ACHV 0.23
- MACD
- YSXT 0.00
- ACHV 0.05
- Stochastic Oscillator
- YSXT 0.00
- ACHV 65.82
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.